Tag: healthcare-services
Evolent Health Stock Analysis: Buy or Sell? Leverage, FCF Yield & Margin Risk
Evolent Health (EVH) carries a Strong Sell rating because its 25.4% FCF yield and strong cash generation do not offset 14.0x net debt/EBITDA and negative operating margin. The balance sheet remains the central risk, even with revenue growth and a cheap EV/revenue multiple.
Nutex Health Stock Analysis: Buy or Sell? Free Cash Flow, Valuation, Reimbursement Risk
Nutex Health Inc. (NUTX) is rated Buy in this stock analysis because it is already turning revenue into strong free cash flow, with a 15.6% FCF yield and 19.2% FCF margin. The key risk is reimbursement and arbitration exposure, which could pressure earnings if disputed claims stay elevated.